Madrigal pharmaceuticals to present at the 42nd annual j.p. morgan healthcare conference

Conshohocken, pa., jan. 03, 2024 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq: mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), announced today that the company will present at the 42nd annual j.p. morgan healthcare conference on wednesday, january 10, 2024 at 4:30 pm pt.
MDGL Ratings Summary
MDGL Quant Ranking